Zosano Pharma Corporation (ZSAN) Stock Cash Flow
NASDAQ:ZSAN - Nasdaq - US98979H3012 - Common Stock
| TTM (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -55.20M | -29.93M | -33.37M | -37.59M | -35.36M | |||
| Depreciation Amortization | 1.56M | 1.75M | 1.43M | 680.00K | 760.00K | |||
| Change In Working Capital | -2.81M | -1.00M | -2.62M | -680.00K | 2.98M | |||
| Interest Paid | 500.00K | 620.00K | 960.00K | 830.00K | 880.00K | |||
| Taxes Paid | N/A | N/A | 10.00K | 0.00 | 0.00 | |||
| Other non cash items | 27.77M | 1.59M | 2.85M | 2.77M | 2.49M | |||
| OPERATING CASH FLOW | -28.67M | -27.59M | -31.72M | -34.82M | -29.12M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.25M | -5.42M | -8.49M | -11.76M | -5.49M | |||
| Other Investing Activity | N/A | N/A | 0.00 | 13.92M | -13.72M | |||
| INVESTING CASH FLOW | -2.25M | -5.42M | -8.49M | 2.16M | -19.21M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -6.74M | -4.79M | -630.00K | 3.05M | 220.00K | |||
| Stock Issued/Repurchased | 24.31M | 13.58M | 69.78M | 26.78M | 45.60M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 17.56M | 8.79M | 69.15M | 29.83M | 45.82M | |||
| CHANGE IN CASH | -13.36M | -24.22M | 28.94M | -2.83M | -2.51M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -28.67M | -27.59M | -31.72M | -34.82M | -29.12M | |||
| Capital Expenditure | -2.25M | -5.42M | -8.49M | -11.76M | -5.49M | |||
| FREE CASH FLOW | -30.92M | -33.01M | -40.21M | -46.58M | -34.61M | |||
All data in USD